Sublingual apomorphine
US9044475B2 · kind B2 · utility
13Cited by
38References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2010 |
| Grant date | Jun 2, 2015 |
| Priority date | — |
| Expiry date | Jun 11, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features sublingual formulations of apomorphine that is a mucoadhesive polymer film or a strip having a first portion including an acid addition salt of apomorphine and a second portion including a pH neutralizing agent, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders by administering sublingually the film or strip.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.